US Drug Recall Register

FDA Drug Recalls

14,801 recalls, newest first

Class II · Moderate risk Terminated

Acetaminophen Infant Dye Free Grape Oral Suspension

Reason CGMP Deviations: Products were manufactured with contaminated excipient that was recalled from the excipient supplier.

Perrigo Company PLC D-0596-2022
Class II · Moderate risk Terminated

Acetaminophen Infant Dye Free Grape Oral Suspension

Reason CGMP Deviations: Products were manufactured with contaminated excipient that was recalled from the excipient supplier.

Perrigo Company PLC D-0595-2022
Class II · Moderate risk Terminated

Acetaminophen Child Strawberry Oral Suspension

Reason CGMP Deviations: Products were manufactured with contaminated excipient that was recalled from the excipient supplier.

Perrigo Company PLC D-0594-2022
Class II · Moderate risk Terminated

Acetaminophen Child Strawberry Oral Suspension

Reason CGMP Deviations: Products were manufactured with contaminated excipient that was recalled from the excipient supplier.

Perrigo Company PLC D-0593-2022
Class II · Moderate risk Terminated

Acetaminophen Infant Dye Free Grape Oral Suspension

Reason CGMP Deviations: Products were manufactured with contaminated excipient that was recalled from the excipient supplier.

Perrigo Company PLC D-0584-2022
Class II · Moderate risk Terminated

Acetaminophen Child Strawberry Oral Suspension

Reason CGMP Deviations: Products were manufactured with contaminated excipient that was recalled from the excipient supplier.

Perrigo Company PLC D-0583-2022
Class II · Moderate risk Terminated

Acetaminophen Oral Suspension Grape Flavor

Reason CGMP Deviations: Products were manufactured with contaminated excipient that was recalled from the excipient supplier.

Perrigo Company PLC D-0579-2022
Class III · Low risk Terminated

Topiramate Tablets

Reason Discoloration

Unichem Pharmaceuticals USA INC NDC 29300-116-05 D-0255-2022
Class II · Moderate risk Terminated

Tadalafil Tablets

Reason Incorrect Product Formulation: An incorrect grade of Crospovidone was used to manufacture the product.

Sun Pharmaceutical Industries INC NDC 16714-077-01 D-0231-2022
Class II · Moderate risk Terminated

Tadalafil Tablets

Reason Incorrect Product Formulation: An incorrect grade of Crospovidone was used to manufacture the product.

Sun Pharmaceutical Industries INC NDC 16714-075-01 D-0230-2022
Class II · Moderate risk Terminated

Pregabalin Capsules

Reason Failed Tablet/Capsule Specifications: Out of Specification results for particle Size Distribution and Bulk Density of the Active Pharmaceutical Ingredient.

Sun Pharmaceutical Industries INC NDC 47335-687-88 D-0361-2022
Class III · Low risk Terminated

Gatifloxacin Ophthalmic Solution

Reason Failed Stability Specifications: Out-of-specification results observed in a water loss test that might affect the assay content and alter drug concentration.

Lupin Pharmaceuticals Inc. NDC 68180-435-01 D-0091-2022